This inventor holds 4 USPTO granted patents and 8 published patent applications and 4 EPO patents. Top assignee: Novartis Ag. Active years: 2021-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2026
Title: The Innovations of Erik Wallström
Introduction
Erik Wallström is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of medicine, particularly in the treatment of multiple sclerosis. With a total of 4 patents to his name, Wallström's work is recognized for its innovative approaches to healthcare.
Latest Patents
One of Wallström's latest patents focuses on "Regimens and methods of treating multiple sclerosis using ofatumumab." This patent outlines treatment regimens that utilize the administration of ofatumumab, an anti-CD20 monoclonal antibody, to patients during both a loading dose regimen and a maintenance regimen. This innovative approach aims to improve the efficacy of treatments for multiple sclerosis, providing new hope for patients suffering from this condition.
Career Highlights
Erik Wallström is currently associated with Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to collaborate with other experts in the field, further enhancing the impact of his inventions. His dedication to advancing medical treatments has positioned him as a key figure in the pharmaceutical industry.
Collaborations
Wallström has worked alongside talented colleagues such as Marina Savelieva Praz and Algirdas Jonas Kakarieka Weisskopf. These collaborations have fostered a creative environment that encourages innovation and the development of groundbreaking treatments.
Conclusion
Erik Wallström's contributions to the field of medicine through his patents and collaborations highlight his commitment to improving patient care. His innovative approaches to treating multiple sclerosis demonstrate the potential for advancements in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
